Oral Bioavailability of Two Solid Formulations of GLPG0259.
NCT01322451
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
GLPG0259 fumarate
DRUG:
GLPG0259 free base
Sponsor
Lakefront Biotherapeutics NV